Visagie, M.H. (Michelle Helen); Birkholtz, Lyn-Marie; Joubert, Annie M.
(BioMed Central, 2015-04-22)
INTRODUCTION : Research involving antimitotic compounds identified 2-methoxyestradiol (2ME2), as a promising anticancer
endogenous metabolite. Owing to its low bioavailability, several in silico-designed 2ME2 analogues ...